Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.
about
Diphtheria toxin-mediated ablation of lymphatic endothelial cells results in progressive lymphedema.Smooth muscle cell recruitment to lymphatic vessels requires PDGFB and impacts vessel size but not identity.Transient loss of venous integrity during developmental vascular remodeling leads to red blood cell extravasation and clearance by lymphatic vessels.Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program.A novel podoplanin-GFPCre mouse strain for gene deletion in lymphatic endothelial cells.Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms.
P2860
Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.
@en
Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.
@nl
type
label
Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.
@en
Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.
@nl
prefLabel
Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.
@en
Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.
@nl
P2093
P2860
P50
P1433
P1476
Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system
@en
P2093
Lukas Stanczuk
Maike Frye
Rodrigo Diéguez-Hurtado
Sagrario Ortega
Taija Makinen
P2860
P2888
P304
P356
10.1007/S10456-016-9505-X
P577
2016-03-18T00:00:00Z